CD8A and gastric cancer: Moreover, a recent study based on scRNA-seq and paired scTCR/BCR-seq showed that antigen-specific ISG-15+CD8+ T cells are able to predict immunotherapy responses in Epstein-Barr virus (EBV)-associated gastric cancer patients [97].